CATAFLAM
DICLOFENAC
Public price
27,85 MAD
Reimbursement base
27,85 MAD
Active substance
DICLOFENAC
Reimbursable
What is this medicine?
Diclofenac sodium delayed-release tablets are a benzene-acetic acid derivative and a nonsteroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory, analgesic, and antipyretic activities.
Verified summary
DICLOFENAC, GOUTTES BUVABLES, 1.5 %, 1 FLACON 15 ML
Common uses
Relief of signs and symptoms of osteoarthritis,Relief of signs and symptoms of rheumatoid arthritis,Acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis
Class
Nonsteroidal anti-inflammatory drug (NSAID)
Availability note
Reimbursable
Hospital price
18,40 MAD
Strength
1.5 %
Form
GOUTTES BUVABLES
Presentation
1 FLACON 15 ML
Type
P
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2017-12-18: 27,85 MAD
Available presentations and strengths
CATAFLAM 50 MG
50 MG · Boîte de 10
22,40 MAD
CATAFLAM 25 MG
25 MG · Boîte de 20
23,00 MAD
CATAFLAM 50 MG
50 MG · 1 BOITE 10 COMPRIME ENROBE
24,00 MAD
CATAFLAM
25 MG · 1 BOITE 20 COMPRIME
24,60 MAD
CATAFLAM
75 MG · 1 BOITE 10 SUPPOSITOIRE
29,50 MAD
CATAFLAM 75 MG
75 MG · Boîte de 10
29,50 MAD
CATAFLAM 50 MG
50 MG · Boîte de 20
42,60 MAD
CATAFLAM
50 MG · 1 BOITE 20 COMPRIME
45,50 MAD
Medicines with the same active substance
DICLOBERL
75 MG · 1 BOITE 1 AMPOULE INJECTABLE
9,70 MAD
DIFAL 25 MG
25 MG · Boîte de 10
11,10 MAD
VOLTARENE
12.5 MG · 1 BOITE 10 SUPPOSITOIRE
11,70 MAD
VOLTARENE 12.5 MG
12.5 MG · Boîte de 10
11,70 MAD
CENIX
25 MG · BOITE DE 10
11,80 MAD
DICLO PHARMA 5
25 MG · BOITE DE 10
11,80 MAD
DIFAL
25 MG · 1 BOITE 10 SUPPOSITOIRE
11,90 MAD
CLOFENE
75 MG · 1 BOITE 1 AMPOULE INJECTABLE
12,30 MAD
CLOFENE 75 MG
75 MG · Boîte de 1 ampoule de 3 ml
12,30 MAD
XENID 25 MG
25 MG · Boîte de 10
12,60 MAD
XENID
25 MG · 1 BOITE 10 SUPPOSITOIRE
13,40 MAD
DICLO PHARMA5 75 MG / 3 ML
75 MG / 3 ML · Boîte de 2
14,00 MAD
